Dihydro-spiro[8-azabicyclo-[3.2.1]octane-3,2'(3'H)-furan]

Catalog No. :
ACFVYZ682
CAS No. :
556062-54-5
Molecular Formula :
C10H17NO
Molecular Weight :
167.25

IUPAC Name:dihydro-3'H-8-azaspiro[bicyclo[3.2.1]octane-3,2'-furan]

Dihydro-spiro[8-azabicyclo-[3.2.1]octane-3,2'(3'H)-furan] structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$833.00Login to see priceIn stockInquiry
250mg95%$1334.00Login to see priceIn stockInquiry
500mg95%$2223.00Login to see priceIn stockInquiry
1g95%$3332.00Login to see priceInquiryInquiry
5g95%$9994.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameDihydro-spiro[8-azabicyclo-[3.2.1]octane-3,2'(3'H)-furan]
IUPAC Namedihydro-3'H-8-azaspiro[bicyclo[3.2.1]octane-3,2'-furan]
MDL No.MFCD23106088
Molecular FormulaC10H17NO
Molecular Weight167.25
SMILESC1(N2)CC3(OCCC3)CC2CC1
InChI KeyNXUJOZPJMSUGDY-UHFFFAOYSA-N
Synonym556062-54-5 | Dihydro-spiro[8-azabicyclo-[3.2.1]octane-3,2'(3'H)-furan] | Dihydro-spiro[8-azabicyclo[3.2.1]octane-3,2'(3'H)-furan] | spiro[8-azabicyclo[3.2.1]octane-3,2'-oxolane] | dihydro-3'H-8-azaspiro[bicyclo[3.2.1]octane-3,2'-furan] | PB39066 | SB2085
CAS No.556062-54-5
PubChem CID72208259

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACFVYZ682 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFVYZ682 route product structure diagram
    ACFVYZ682556062-54-5 In Stock
Inquiry

2. ACFVYZ682 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFVYZ682 route product structure diagram
    ACFVYZ682556062-54-5 In Stock
Inquiry

Comments (0)